A recent study by Scarpa et al. (2016) clearly identified that any two or more methylated genes (APC, CDH13, MGMT, MLH1 and RUNX3) in the non-neoplastic mucosa could predict CRC with a sensitivity of 57.1% and a specificity of 93.1%. The gene discussed is RUNX3; the disease is colorectal carcinoma.